← All indications
Endocarditis
Inflammation of the inner lining of the heart (ENDOCARDIUM), the continuous membrane lining the four chambers and HEART VALVES. It is often caused by microorganisms including bacteria, viruses, fungi, and rickettsiae. Left untreated, endocarditis can damage heart valves and become life-threatening.
Subtype terms (2)
More specific conditions that are subtypes of Endocarditis in the MeSH hierarchy.
- Endocarditis, Bacterial
13 drugs (11 approved, 2 experimental)
- Endocarditis, Non-Infective
Drugs by status
Approved for this indication (13)
Phase 4 trials (25)
- levofloxacin
- ceftaroline fosamil
- clavulanate
- doxycycline
- dicloxacillin
- fosfomycin
- fusidic acid
- rifampin
- amoxicillin
- potassium chloride
- ceftriaxone
- sulfamethoxazole
- tedizolid phosphate
- ciprofloxacin
- gentamicin
- trovafloxacin
- moxifloxacin
- clindamycin
- cefaclor
- cephalexin
- cefepime
- technetium tc 99m sulesomab
- trimethoprim
- oxacillin
- ampicillin
Phase 3 trials (1)
Other trials (4)
Organizations
Organization Involved with Phase 4 Indications (19)
- Cubist
- University of Pennsylvania
- Cornell University
- Henry Ford Health System
- Nanjing Medical University
- Shengjing Hospital
- University of Santiago de Compostela
- Yonsei University
- Soochow University
- Zhejiang Chinese Medical University
- Zhejiang University
- Shandong University
- Santiago de Compostela University
- University of Santiago
- Tianjin Medical University
- University of Lyon
- Sun Yat-Sen University
- University of Barcelona
- People's Liberation Army of China
Organization Involved with Phase 3 Indications (3)
Organization Involved with Phase 2 Indications (4)
Organization Involved with Other Experimental Indications (2)